The US has launched an investigation into drug prices in Germany, where health insurance companies would impose high discounts on pharmaceutical companies, leading to higher costs for US patients.
The US has launched an investigation into drug prices in Germany, where health insurance companies would impose high discounts on pharmaceutical companies, leading to higher costs for US patients.